Business
A Vaccine Against a Widespread Common Cold Type Just Passed Promising Clinical Trials – ScienceAlert
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
The cold, known as respiratory syncytial virus (RSV), is so common, more than 90 percent of kids contract it by the age of two. In fact, this dangerous and sometimes deadly infection is the leading cause of serious lower respiratory diseases in children worldwide…
-
Noosa News23 hours agoTwo in five Brisbane streets have no footpaths, with council building about 4km of new paths last year
-
Noosa News22 hours agoWeather to warm up in Queensland, as more rain forecast for the north
-
General22 hours agoNZ offers blueprint for home-building productivity fix
-
Noosa News23 hours agoDementia now leading cause of death for Australians